Abeza Tablet

About Abeza 150 mg Tablet

Made by Beacon Pharmaceuticals PLC, Abeza is a tablet whose active ingredient is Abemaciclib. It is given together with hormonal therapy such as tamoxifen or an aromatase inhibitor, and in some situations as a single treatment.

There are 6 brands of Abemaciclib listed in Bangladesh. By unit price, Abeza is among the cheapest of them.

What is Abeza 150 mg Tablet?

Abeza 150 mg is a tablet product of Beacon Pharmaceuticals PLC that contains Abemaciclib. Abemaciclib works as a protein kinase inhibitor: it blocks certain proteins that help cancer cells divide and grow. Do not change or stop the medicine unless your doctor tells you to.

Uses of Abeza

It is given together with hormonal therapy such as tamoxifen or an aromatase inhibitor, and in some situations as a single treatment. It is not a general-purpose medicine and should only be used under cancer specialist care. Your doctor will decide if it is suitable for you.

How to use Abeza

Abeza 150 mg tablet is swallowed whole, with or without food, as directed by the cancer specialist. Abeza is taken by mouth. Swallow the tablet with water. Complete the course exactly as prescribed. The doctor decides the dose and how long you take it, and may change the schedule depending on how you tolerate it.

Side effects of Abeza

Because some effects can become serious, tell the doctor promptly about loose stools, fever, unusual bruising or bleeding, or any new breathing difficulty. Blood counts can also drop, which may show up as low white cells, low red cells or low platelets. Some people develop serious problems, including severe diarrhea with dehydration, low white cell counts, and lung inflammation. Your doctor will advise on managing side effects. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

Abeza can harm an unborn baby, so pregnant women should speak to their doctor before starting it. Breastfeeding should be discussed with the doctor. Ask your doctor first if any of these apply to you.

Frequently asked questions

Why is Abeza prescribed?

It is given together with hormonal therapy such as tamoxifen or an aromatase inhibitor, and in some situations as a single treatment. It is not a general-purpose medicine and should only be used under cancer specialist care.

How do I use Abeza correctly?

Abeza 150 mg tablet is swallowed whole, with or without food, as directed by the cancer specialist. Abeza is taken by mouth.

What should I watch for while using Abeza?

Because some effects can become serious, tell the doctor promptly about loose stools, fever, unusual bruising or bleeding, or any new breathing difficulty. Blood counts can also drop, which may show up as low white cells, low red cells or low platelets.

What is the price of Abeza?

The listed price is ৳ 950.00.

Also available as

200 mg (Tablet)

Indications

Abeza is a kinase inhibitor indicated:
  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
  • ... Read more
Abeza is a kinase inhibitor indicated:
  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
  • in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
  • in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
  • as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.

Pharmacology

Abemaciclib is an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4 and CDK6). These kinases are activated upon binding to D-cyclins. In estrogen receptor-positive (ER+) breast cancer cell lines, cyclin D1 and CDK4/6 promote phosphorylation of the retinoblastoma protein (Rb), cell cycle progression, and cell proliferation. In vitro, continuous exposure to abemaciclib inhibited Rb phosphorylation and blocked progression from G1 into S phase of the cell cycle, resulting in senescence and apoptosis. In breast cancer xenograft models, abemaciclib dosed daily without interruption as a single agent or in combination with antiestrogens resulted in reduction of tumor size.

Dosage & Administration

Abemaciclib tablets are taken orally with or without food.
  • Recommended starting dose in combination with fulvestrant, tamoxifen, or an aromatase inhibitor: 150 mg twice daily.
  • Recommended starting dose as monotherapy: 200 mg twice daily.
  • Dosing interruption and/or dose reductions may be required based on individual safety and tolerability.

Interaction

CYP3A Inhibitors: Avoid concomitant use of ketoconazole. Reduce the Abeza dose with concomitant use of other strong and moderate CYP3A inhibitors.
CYP3A Inducers: Avoid concomitant use of strong and moderate CYP3A inducers.

Side Effects

Most common adverse reactions (incidence ≥20%) were diarrhea, neutropenia, nausea, abdominal pain, infections, fatigue, anemia, leukopenia, decreased appetite, vomiting, headache, alopecia, and thrombocytopenia.

Pregnancy & Lactation

Based on findings from animal studies and the mechanism of action, Abemaciclib can cause fetal harm when administered to a pregnant woman. In animal reproduction studies, administration of abemaciclib to pregnant rats during the period of organogenesis caused teratogenicity and decreased fetal weight at maternal exposures that were similar to the human clinical exposure based on area under the curve (AUC) at the maximum recommended human dose. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with Abemaciclib and for 3 weeks after the last dose.

Precautions & Warnings

Diarrhea: Abeza can cause severe cases of diarrhea, associated with dehydration and infection. Instruct patients at the first sign of loose stools to initiate antidiarrheal therapy, increase oral fluids, and notify their healthcare provider.

Neutropenia: Monitor complete blood counts prior to the start of Abeza therapy, every 2 weeks for the first 2 months, monthly for the next 2 months, and as clinically indicated.

Interstitial Lung Disease (ILD)/Pneumonitis: Severe and fatal cases of ILD/pneumonitis have been reported. Monitor for clinical symptoms or radiological changes indicative of ILD/pneumonitis. Permanently discontinue Abeza in all patients with Grade 3 or 4 ILD or pneumonitis.

Hepatotoxicity: Increases in serum transaminase levels have been observed. Perform liver function tests (LFTs) before initiating treatment with Abeza. Monitor LFTs every two weeks for the first two months, monthly for the next 2 months, and as clinically indicated.

Venous Thromboembolism: Monitor patients for signs and symptoms of thrombosis and pulmonary embolism and treat as medically appropriate.

Embryo-Fetal Toxicity: Can cause fetal harm. Advise patients of potential

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Abemaciclib

Other brands with the same generic name, cheapest first.

Abeza Tablet

200 mg

Abemaciclib

Beacon Pharmaceuticals PLC

৳ 1150.00 per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.